COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS Application US-20220288074-A1 United States of America 15 Sep 2022
COMBINATION OF ENCORAFENIB AND BINIMETINIB AS ADJUVANT TREATMENT FOR RESECTED STAGE II… Application WO-2022074011-A1 World Intellectual Property Organisation (WIPO) 14 Apr 2022